MEDICREA Appoints New Vice President Of U.S. Sales

NEW YORK & LYON, France--(BUSINESS WIRE)--The MEDICREA group (Paris:ALMED)(Alternext Paris: FR0004178572 - ALMED), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, today announced that Gregory Rhinehart has joined the company’s US-based subsidiary, MEDICREA USA Corp., as Vice President of Sales.

Help employers find you! Check out all the jobs and post your resume.